KR 6346

Drug Profile

KR 6346

Latest Information Update: 14 Feb 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gedeon Richter; Kowa
  • Class Antiulcers; Cytoprotectives; Small molecules; Thiazolidines
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Peptic ulcer

Most Recent Events

  • 14 Feb 1996 Discontinued-Preclinical for Peptic ulcer in Hungary (Unknown route)
  • 14 Feb 1996 Discontinued-Preclinical for Peptic ulcer in Japan (Unknown route)
  • 20 Sep 1995 Investigation in Peptic ulcer in Hungary (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top